|
1
|
Direct involvement of orexinergic systems in the activation of the mesolimbic dopamine pathway and related behaviors induced by morphine.
|
J Neurosci
|
2006
|
2.84
|
|
2
|
Direct evidence of astrocytic modulation in the development of rewarding effects induced by drugs of abuse.
|
Neuropsychopharmacology
|
2006
|
1.39
|
|
3
|
Direct evidence for the involvement of brain-derived neurotrophic factor in the development of a neuropathic pain-like state in mice.
|
J Neurochem
|
2005
|
1.21
|
|
4
|
Hippocampal epigenetic modification at the brain-derived neurotrophic factor gene induced by an enriched environment.
|
Hippocampus
|
2011
|
1.20
|
|
5
|
Direct evidence for spinal cord microglia in the development of a neuropathic pain-like state in mice.
|
J Neurochem
|
2006
|
1.20
|
|
6
|
Direct evidence for the involvement of endogenous beta-endorphin in the suppression of the morphine-induced rewarding effect under a neuropathic pain-like state.
|
Neurosci Lett
|
2008
|
1.17
|
|
7
|
Suppression of the morphine-induced rewarding effect in the rat with neuropathic pain: implication of the reduction in mu-opioid receptor functions in the ventral tegmental area.
|
J Neurochem
|
2002
|
1.10
|
|
8
|
Enhanced IL-1beta production in response to the activation of hippocampal glial cells impairs neurogenesis in aged mice.
|
Synapse
|
2010
|
1.07
|
|
9
|
Role of extracellular signal-regulated kinase in the ventral tegmental area in the suppression of the morphine-induced rewarding effect in mice with sciatic nerve ligation.
|
J Neurochem
|
2004
|
1.05
|
|
10
|
Epigenetic transcriptional activation of monocyte chemotactic protein 3 contributes to long-lasting neuropathic pain.
|
Brain
|
2013
|
1.01
|
|
11
|
Protease-activated receptor-1 and platelet-derived growth factor in spinal cord neurons are implicated in neuropathic pain after nerve injury.
|
J Neurosci
|
2005
|
1.01
|
|
12
|
Involvement of a spinal brain-derived neurotrophic factor/full-length TrkB pathway in the development of nerve injury-induced thermal hyperalgesia in mice.
|
Brain Res
|
2002
|
0.99
|
|
13
|
Memory impairment associated with a dysfunction of the hippocampal cholinergic system induced by prenatal and neonatal exposures to bisphenol-A.
|
Neurosci Lett
|
2007
|
0.98
|
|
14
|
Chronic pain-induced emotional dysfunction is associated with astrogliosis due to cortical delta-opioid receptor dysfunction.
|
J Neurochem
|
2006
|
0.96
|
|
15
|
Change in microRNAs associated with neuronal adaptive responses in the nucleus accumbens under neuropathic pain.
|
J Neurosci
|
2011
|
0.94
|
|
16
|
Astrocytic activation in the anterior cingulate cortex is critical for sleep disorder under neuropathic pain.
|
Synapse
|
2014
|
0.92
|
|
17
|
Suppression of enriched environment-induced neurogenesis in a rodent model of neuropathic pain.
|
Neurosci Lett
|
2008
|
0.92
|
|
18
|
к Opioids inhibit tumor angiogenesis by suppressing VEGF signaling.
|
Sci Rep
|
2013
|
0.90
|
|
19
|
Differential involvement of spinal protein kinase C and protein kinase A in neuropathic and inflammatory pain in mice.
|
Brain Res
|
2003
|
0.90
|
|
20
|
Disruption of the type 1 inositol 1,4,5-trisphosphate receptor gene suppresses the morphine-induced antinociception in the mouse.
|
Neurosci Lett
|
2003
|
0.90
|
|
21
|
Neuronal protein kinase C gamma-dependent proliferation and hypertrophy of spinal cord astrocytes following repeated in vivo administration of morphine.
|
Eur J Neurosci
|
2004
|
0.89
|
|
22
|
Chronic pain-induced astrocyte activation in the cingulate cortex with no change in neural or glial differentiation from neural stem cells in mice.
|
Neurosci Lett
|
2007
|
0.89
|
|
23
|
Sleep disturbances in a neuropathic pain-like condition in the mouse are associated with altered GABAergic transmission in the cingulate cortex.
|
Pain
|
2011
|
0.88
|
|
24
|
Effect of repeated administration of morphine on the activity of extracellular signal regulated kinase in the mouse brain.
|
Neurosci Lett
|
2002
|
0.88
|
|
25
|
Multiple analyses of G-protein coupled receptor (GPCR) expression in the development of gefitinib-resistance in transforming non-small-cell lung cancer.
|
PLoS One
|
2012
|
0.87
|
|
26
|
Direct evidence for the activation of phospholipase C gamma 1 by in vivo treatment with morphine in the mouse periaqueductal gray matter.
|
Brain Res
|
2003
|
0.87
|
|
27
|
Change in the expression of c-fos in the rat brain following sciatic nerve ligation.
|
Neurosci Lett
|
2003
|
0.86
|
|
28
|
Prenatal and neonatal exposure to bisphenol-A affects the morphine-induced rewarding effect and hyperlocomotion in mice.
|
Neurosci Lett
|
2004
|
0.86
|
|
29
|
Long-lasting change in brain dynamics induced by methamphetamine: enhancement of protein kinase C-dependent astrocytic response and behavioral sensitization.
|
J Neurochem
|
2005
|
0.86
|
|
30
|
Reduced expression of a novel mu-opioid receptor (MOR) subtype MOR-1B in CXBK mice: implications of MOR-1B in the expression of MOR-mediated responses.
|
Eur J Neurosci
|
2003
|
0.86
|
|
31
|
Analysis of sleep disorders under pain using an optogenetic tool: possible involvement of the activation of dorsal raphe nucleus-serotonergic neurons.
|
Mol Brain
|
2013
|
0.85
|
|
32
|
Involvement of microglia in the ethanol-induced neuropathic pain-like state in the rat.
|
Neurosci Lett
|
2006
|
0.85
|
|
33
|
Changes in function of NMDA receptor NR2B subunit in spinal cord of rats with neuropathy following chronic ethanol consumption.
|
Life Sci
|
2006
|
0.85
|
|
34
|
The κ opioid system regulates endothelial cell differentiation and pathfinding in vascular development.
|
Blood
|
2011
|
0.85
|
|
35
|
Implication of dopaminergic projection from the ventral tegmental area to the anterior cingulate cortex in μ-opioid-induced place preference.
|
Addict Biol
|
2010
|
0.84
|
|
36
|
Hippocampal epigenetic modification at the doublecortin gene is involved in the impairment of neurogenesis with aging.
|
Synapse
|
2010
|
0.83
|
|
37
|
Differences in tolerance to anti-hyperalgesic effects between chronic treatment with morphine and fentanyl under a state of pain.
|
Nihon Shinkei Seishin Yakurigaku Zasshi
|
2006
|
0.83
|
|
38
|
Post-synaptic action of morphine on glutamatergic neuronal transmission related to the descending antinociceptive pathway in the rat thalamus.
|
J Neurochem
|
2008
|
0.82
|
|
39
|
Increased phosphorylated-mu-opioid receptor immunoreactivity in the mouse spinal cord following sciatic nerve ligation.
|
Neurosci Lett
|
2004
|
0.82
|
|
40
|
Enhancement of glutamatergic transmission in the cingulate cortex in response to mild noxious stimuli under a neuropathic pain-like state.
|
Synapse
|
2010
|
0.81
|
|
41
|
Implication of cyclin-dependent kinase 5 in the development of psychological dependence on and behavioral sensitization to morphine.
|
J Neurochem
|
2005
|
0.81
|
|
42
|
Changes in central dopaminergic systems with the expression of Shh or GDNF in mice perinatally exposed to bisphenol-A.
|
Nihon Shinkei Seishin Yakurigaku Zasshi
|
2007
|
0.80
|
|
43
|
Molecular mechanism of changes in the morphine-induced pharmacological actions under chronic pain-like state: suppression of dopaminergic transmission in the brain.
|
Life Sci
|
2004
|
0.80
|
|
44
|
Intensification of the development of ethanol dependence in mice lacking dopamine D(3) receptor.
|
Neurosci Lett
|
2002
|
0.79
|
|
45
|
Role of Src family kinase in the rewarding effect and hyperlocomotion induced by morphine.
|
Neuroreport
|
2006
|
0.79
|
|
46
|
Epigenetic modulation at the CCR2 gene correlates with the maintenance of behavioral sensitization to methamphetamine.
|
Addict Biol
|
2010
|
0.79
|
|
47
|
Molecular evidence for the functional role of dopamine D3 receptor in the morphine-induced rewarding effect and hyperlocomotion.
|
J Neurosci
|
2003
|
0.79
|
|
48
|
Direct evidence for the ongoing brain activation by enhanced dynorphinergic system in the spinal cord under inflammatory noxious stimuli.
|
Anesthesiology
|
2010
|
0.79
|
|
49
|
Functional changes in dopamine D3 receptors by prenatal and neonatal exposure to an endocrine disruptor bisphenol-A in mice.
|
Addict Biol
|
2004
|
0.79
|
|
50
|
[Difference in tolerance to anti-hyperalgesic effect and its molecular mechanisms between chronic treatment with morphine, fentanyl and oxycodone in a chronic pain-like state].
|
Nihon Shinkei Seishin Yakurigaku Zasshi
|
2008
|
0.78
|
|
51
|
Activation of extracellular signal-regulated kinase is critical for the discriminative stimulus effects induced by U-50,488H.
|
Synapse
|
2011
|
0.78
|
|
52
|
Chronic morphine treatment increases the expression of the neural cell adhesion molecule in the dorsal horn of the mouse spinal cord.
|
Neurosci Lett
|
2006
|
0.78
|
|
53
|
Changes in circadian rhythm for mRNA expression of melatonin 1A and 1B receptors in the hypothalamus under a neuropathic pain-like state.
|
Synapse
|
2014
|
0.77
|
|
54
|
Role of spinal voltage-dependent calcium channel alpha 2 delta-1 subunit in the expression of a neuropathic pain-like state in mice.
|
Life Sci
|
2007
|
0.77
|
|
55
|
Involvement of spinal metabotropic glutamate receptor 5 in the development of tolerance to morphine-induced antinociception.
|
J Neurochem
|
2005
|
0.77
|
|
56
|
Chronic morphine treatment increases the expression of vesicular glutamate transporter 1 in the mouse spinal cord.
|
Eur J Pharmacol
|
2006
|
0.77
|
|
57
|
Influence of a deletion of protein kinase C gamma isoform in the G-protein activation mediated through opioid receptor-like-1 and mu-opioid receptors in the mouse pons/medulla.
|
Neurosci Lett
|
2002
|
0.77
|
|
58
|
Involvement of mGluR5 in the ethanol-induced neuropathic pain-like state in the rat.
|
Neurosci Lett
|
2006
|
0.77
|
|
59
|
Induction of c-fos expression in the mouse brain associated with hyperalgesia induced by intrathecal injection of protein kinase C activator.
|
Brain Res
|
2004
|
0.76
|
|
60
|
Implication of Src family kinase-dependent phosphorylation of NR2B subunit-containing NMDA receptor in the rewarding effect of morphine.
|
Nihon Shinkei Seishin Yakurigaku Zasshi
|
2006
|
0.76
|
|
61
|
Functional role of cortical astrocytes in sleep/affective dysregulation under the chronic pain: analysis by artificial control of astrocytes using optogenetics.
|
Nihon Yakurigaku Zasshi
|
2016
|
0.75
|
|
62
|
Up-regulation of mu-opioid receptor-mediated G-protein activation in protein kinase Cgamma knockout mice following repeated naloxone treatment.
|
Neurosci Lett
|
2003
|
0.75
|
|
63
|
Upregulation of bradykinin receptors is implicated in the pain associated with caerulein-induced acute pancreatitis.
|
Synapse
|
2010
|
0.75
|
|
64
|
Suppression of dopamine-related side effects of morphine by aripiprazole, a dopamine system stabilizer.
|
Eur J Pharmacol
|
2008
|
0.75
|
|
65
|
[The functional change in the 5-HT1A receptor induced by stress and the role of the 5-HT1A receptor in neuroprotection].
|
Nihon Shinkei Seishin Yakurigaku Zasshi
|
2005
|
0.75
|
|
66
|
Correction: Multiple Analyses of G-Protein Coupled Receptor (GPCR) Expression in the Development of Gefitinib-Resistance in Transforming Non-Small-Cell Lung Cancer.
|
PLoS One
|
2013
|
0.75
|
|
67
|
Molecular Understanding of the Acquisition of Resistance to Anti-cancer Drugs Associated with the Exacerbation of Cancer.
|
Yakugaku Zasshi
|
2016
|
0.75
|